In a subsequent study, the same authors analyzed the tumor expression of TNF and its regulator SPATA2 in relation to the clinical-pathological characteristics and clinical outcome of patients with endometrial carcinoma (EC) [35]. The gene discussed is SPATA2; the disease is neoplasm.